AzTrials
AzTrials

Urinary IncontinenceNCT04619238

Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women

An observational study of Urinary Incontinence and Overactive Bladder, run by Medical University of Lublin at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women. Read more about this study

Who is it for?
Ages 18 to 82 years, women only
What is being tested?
King's Health Questionnaire and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
How many people
155 participants
Where
1 sitePoland
Study dates
1 Jun 2017to 10 Jan 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 82 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: women age 18-82 years who declared symptoms of urinary incontinence

Who may be able to join

  • informed consent
  • patients with symptoms of urinary incontinence
  • age 18-82 years

Who cannot join

  • lack of consent
  • inability to understand the study protocol

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Katarzyna Skorupska

    Lublin, 20-059

Other trials in Poland

About this study

Official title: Reliability of The King's Health Questionnaire and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form in Assessing Urinary Incontinence Effects in Polish Women

The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women.

Read the detailed description

Purpose The King's Health Questionnaire (KHQ) and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form are widely used in clinical practice. The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women.

Methods One hundred fifty-five women with urinary incontinence (UI) aged between 19-82 years underwent urodynamic investigation and completed both KHQ and ICIQ-SF. To evaluate the factor structure and construct the validity of the KHQ and ICIQ, Principal Component Analysis (PCA) using VARIMAX rotation was conducted for all questionnaire items. PCA results were also confirmed by Spearman's correlations between KHQ and ICIQ items. Moreover, the internal consistency of the KHQ and ICIQ was estimated by way of Cronbach's alpha coefficient (α). Statistical analysis was performed using STATISTICA version 13.1 software (StatSoft, Poland), as well as open source R software (version 3.4.4).

Being tested
King's Health Questionnaire, the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
Keywords
king's health questionnaire, the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
Medical subject headings
Urinary Incontinence, Urinary Bladder, Overactive, Urinary Incontinence, Stress, Urinary Incontinence, Urge

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • King's Health QuestionnaireDiagnostic test

    patients fulfilled questionnaire

  • the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short FormDiagnostic test

    patients fulfilled ICIQ-SF questionnaire

Study groups in NCT04619238
Study groupRoleWhat they receive
no urinary incontinencepatients without UI
Receives: Diagnostic Test: King's Health Questionnaire; Diagnostic Test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
stress urinary incontinencepatients with SUI
Receives: Diagnostic Test: King's Health Questionnaire; Diagnostic Test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
overactive bladderpatients with OAB
Receives: Diagnostic Test: King's Health Questionnaire; Diagnostic Test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
mix urinary incontinencepatients with MUI
Receives: Diagnostic Test: King's Health Questionnaire; Diagnostic Test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
Urgepatients with urge incontinence
Receives: Diagnostic Test: King's Health Questionnaire; Diagnostic Test: the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. psychometric properties of KHQ in polish women with urinary incontinence

    psychometric properties of KHQ

    Measured: 2017-2018

  2. psychometric properties of ICIQ-SF in polish women with urinary incontinence

    psychometric properties of ICIQ-SF

    Measured: 2017-2018

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2020
  2. Study start1 Jun 2017
  3. Primary completion30 Dec 2018
  4. Study completion10 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
155 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04619238
Sponsor's protocol ID
2\2020
Status last verified
Nov 2020
First submitted
2 Nov 2020
Last updated
6 Nov 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Incontinence and Overactive Bladder, run by Medical University of Lublin at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

psychometric properties of KHQ in polish women with urinary incontinence (time frame: 2017-2018). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in